The Effects of Salvia Hispanica-Enriched Foods on Glycemic and Insulinemic Responses and Subjective Satiety

NCT00728065 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2009-02-18

No results posted yet for this study

Summary

Salvia hispanic (Salba) is postulated to increase satiety. This study determines the optimal amount of Salba as well as whether liquid or solid enriched products will produce maximum satiety. The results can gauge the effectiveness of Salba in weight loss programs. The study has a randomized, double-blind crossover design which includes 10 test meals and capillary blood sampling to perform glucose and insulin analyses (to determine blood glucose response and blood insulin response).

Conditions

  • Post Prandial Blood Glucose

Interventions

DIETARY_SUPPLEMENT

White Bread

About 100g of white bread consisting of 50g of available carbohydrates, served with 250mL water

DIETARY_SUPPLEMENT

White bread with added 7.32g Salvia hispanica

About 100g of white bread consisting of 50g of available carbohydrates and 7.32g Salvia hispanica, served with 250mL water

DIETARY_SUPPLEMENT

White bread with added 15.58g Salvia hispanica

About 100g of white bread consisting of 50g of available carbohydrates and 7.32g Salvia hispanica, served with 250mL water

DIETARY_SUPPLEMENT

White bread with added Salvia hispanica

About 100g of white bread consisting of 50g of available carbohydrates and 24g Salvia hispanica, served with 250mL water

DIETARY_SUPPLEMENT

Rice milk

Rice milk containing 50g of available carbohydrates

DIETARY_SUPPLEMENT

Enriched rice milk containing 7.32g Salvia hispanica

Rice milk containing 50g of available carbohydrates with 7.32g added Salvia hispanica

DIETARY_SUPPLEMENT

Enriched rice milk containing 15.58g Salvia hispanica

Rice milk containing 50g of available carbohydrates with 15.58g added Salvia hispanica

DIETARY_SUPPLEMENT

Enriched rice milk containing 24g Salvia hispanica

Rice milk containing 50g of available carbohydrates with 24g added Salvia hispanica

Sponsors & Collaborators

  • Unity Health Toronto

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2008-09-30
Completion
2009-02-28

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00728065 on ClinicalTrials.gov